Do bupivacaine, clindamycin, and gentamicin at their clinical concentrations enhance rocuronium-induced neuromuscular block?

Lee, Soo-Il; Lee, Ji Hyeon; Park, Sang Yoong; Park, Jae-Won
April 2013
Korean Journal of Anesthesiology;Apr2013, Vol. 64 Issue 4, p346
Academic Journal
Background: Bupivacaine, clindamycin, and gentamicin inhibit neuromuscular (NM) conduction. When they are combined, they may synergistically reduce the effective concentration of each to the therapeutic concentration in augmenting rocuronium-induced NM block. Thus, the aim of this study was to investigate whether combinations of the three drugs, at around their therapeutic concentrations, potentiate rocuronium-induced NM block. Methods: Fifty-seven left-phrenic nerve hemidiaphragms (Male S-D rats, 150-250 g) were hung in a 20-ml organ bath filled with Krebs solution. Three consecutive single-twitch tensions (0.1 Hz) and one tetanic tension (50 Hz for 1.9 s) were obtained. A Krebs solution was premixed with concentration sets of bupivacaine and clindamycin, bupivacaine and gentamicin, or bupivacaine, clindamycin and gentamicin. Then, the concentration of rocuronium was cumulatively increased in the Krebs solution (1, 3, 5, 7, 9, 12, 14, 16, 18, and 20 µM) until an 80% to 90% reduction in single twitch was attained. The effective concentrations for each experiment were determined with the probit model. Results: The combinations of bupivacaine, clindamycin, and gentamicin enhanced rocuronium-induced NM block. When the three drugs were applied simultaneously, their concentrations were reduced to near-therapeutic levels in potentiating the action of rocuronium. Conclusions: Bupivacaine, clindamycin, and gentamicin blocked NM conduction, and when all three drugs were applied together, they augmented rocuronium-induced NM block at their near-therapeutic concentrations. Clinicians should be aware of the cooperability in NM block between drugs that interrupt NM conduction.


Related Articles

  • The synergistic effect of gentamicin and clindamycin on rocuronium-induced neuromuscular blockade. Ji Hyeon Lee; Lee, Soo-Il; Chan Jong Chung; Jong Hwan Lee; Seung Cheol Lee; So Ron Choi; Ji Na Oh; Jae Young Bae // Korean Journal of Anesthesiology;Feb2013, Vol. 64 Issue 2, p143 

    Background: Gentamicin reduces acetylcholine release and clindamycin causes end-plate ion channel blockade. Because of these reasons, two drugs show muscular relaxant effect and potentiate the action of nondepolarizing neuromuscular agents. This study was intended to evaluate the effect of...

  • At therapeutic concentration bupivacaine causes neuromuscular blockade and enhances rocuronium-induced blockade. Ji Hyeon Lee; Soo-Il Lee; Seung Cheol Lee; So Ron Choi; Won Ji Rhee // Korean Journal of Anesthesiology;May2012, Vol. 62 Issue 5, p468 

    Background: Partially paralyzed patients may be placed in the risk of pharyngeal dysfunction. Bupivacaine acts as acetylcholine receptor ion channel blocker and may synergistically interact with rocuronium to augment NM blockade. Thus, this study aims to elucidate whether or not, at a...

  • Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients. Suzuki, T.; Kitajima, O.; Ueda, K.; Kondo, Y.; Kato, J.; Ogawa, S. // BJA: The British Journal of Anaesthesia;Jun2011, Vol. 106 Issue 6, p823 

    Background This study compared the reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients. Methods Fifteen younger (20–50 yr) and 15 older (≥70 yr) patients were sequentially enrolled in this study. After induction of...

  • Negative Pressure Pulmonary Edema after Reversing Rocuronium-Induced Neuromuscular Blockade by Sugammadex. Manzo Suzuki; Toshiichiro Inagi; Takehiko Kikutani; Takuya Mishima; Hiroyasu Bito // Case Reports in Anesthesiology;2014, p1 

    Negative pressure pulmonary edema (NPPE) is a rare complication that accompanies general anesthesia, especially after extubation. We experienced a case of negative pressure pulmonary edema after tracheal extubation following reversal of rocuronium-induced neuromuscular blockade by sugammadex. In...

  • Calcium and neostigmine antagonize gentamicin, but augment clindamycin-induced tetanic fade in rat phrenic nerve-hemidiaphragm preparations. SOO-IL LEE; JONG-HWAN LEE; SEUNG CHEOL LEE; JUNG MOO LEE; JI HYEON LEE // Journal of Anesthesia;2008, Vol. 22 Issue 4, p385 

    A reduction in acetylcholine release induced by gentamicin may limit neostigmine-induced increases in acetylcholine concentration in the neuromuscular junction. An increase in acetylcholine concentration caused by neostigmine and calcium may enhance the use-dependent ion channel block of the...

  • Aminoglycoside Resistance in Enterococci. Chow, Joseph W. // Clinical Infectious Diseases;8/1/2000, Vol. 31 Issue 2, p586 

    Focuses on a study which discussed the resistance of aminoglycoside in enterococci. Background of the intrinsic resistance of enterococci to aminoglycosides; Description of gentamicin resistance genes; Alternative approach for synergism prediction.

  • Clinical pharmacokinetics of neuromuscular relaxants in pregnancy. Guay, J.; Grenier, Y.; Varin, F. // Clinical Pharmacokinetics;1998, Vol. 34 Issue 6, p483 

    Despite an increased in bodyweight, plasma volume by 45% and blood volume by 35% that might influence the volume of distribution of polar drugs, the apparent volume of distribution at steady state (Vss), volume of distribution (Vd) and the apparent volume of the central compartment (Vc) of...

  • Clinical Pharmacokinetics of the Newer Neuromuscular Blocking Drugs. Paul, D.; Atherton, L.; Hunter, J.M. // Clinical Pharmacokinetics;1999, Vol. 36 Issue 3, p169 

    The pharmacokinetics of 6 new neuromuscular blocking drugs are described. These are the aminosteroids pipecuronium bromide, rocuronium bromide and rapacuronium bromide (ORG-9487) and the benzylisoquinolinium diesters doxacurium chloride, mivacurium chloride and cisatracurium besilate. In healthy...

  • Rapacuronium Bromide: A Review of its Use in Anaesthetic Practice. Onrust, S.V.; Foster, R.H. // Drugs;Nov1999, Vol. 58 Issue 5, p887 

    Rapacuronium bromide (rapacuronium) is an aminosteroid, nondepolarising neuromuscular blocking agent (NMBA). At the recommended dose for endotracheal intubation (1.5 mg/kg), an intravenous bolus of rapacuronium has a rapid onset (≈1.2 to 1.8 minutes) and short duration of action (10.2 to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics